The landscape of dementia diagnosis has evolved drastically with the advent of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that may detect Alzheimer's pathology years before indications arise. When these technological advancements depict exceptional progress in being familiar with neurodegenerative health conditions, they have https://gastone297blu6.wikistatement.com/user